Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07710781 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

StatusNot Yet Recruiting
PhaseNot applicable
Started2026-12-01
View on ClinicalTrials.gov ↗

Amendment history

2026-09-08
Study Identification, Study Status v2
Re-verified, no change to tracked fields
2026-07-16
Study Identification, Study Status v1
Study title-26 characters
A Multicenter, Open Label Study to Characterize Mismatched to Fully HLA-Matched Ossium [...]
2026-07-13
Original filing
Ossium Health, Inc.
4 trials monitored
See 1 trial at risk
Leukemia
2,553 trials monitored
See 134 trials at risk
Non-Hodgkin Lymphoma
1,512 trials monitored
See 79 trials at risk
Acute Myeloid Leukemia (AML)
1,196 trials monitored
See 63 trials at risk
and 5 more diseases
Prospective, multi-center open label study of HLA-partially to fully matched allogeneic cryopreserved deceased donor bone marrow transplantation and living donor transplantation for patients with hematologic malignancies.
Trial Details
NCT Number NCT07710781
Lead Sponsor Ossium Health, Inc.
Conditions Hematologic Malignancy, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Acute Undifferentiated Leukemia, CLL (Chronic Lymphocytic Leukemia), Chronic Myeloid Leukemia +4 more
Enrollment 300 participants
Start Date 2026-12-01
Primary Completion 2029-03-31 (estimated)
Study Completion 2031-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-10